Inc Agenus serves as Executive at MiNK Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Inc Agenus has executed 17 insider transactions totaling $17.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 16, 2023 involved purchasing 429 shares valued at $472.
Inc Agenus currently holds 21,772,863 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc Agenus has been a net buyer of INKT stock. They have purchased $17.5M and sold $0 worth of shares.
Inc Agenus's most recent insider trade was on Oct 16, 2023, when they purchased 429 shares at $1.10 per share.
Get notified when new Form 4 filings are submitted
| $1.10 |
| Discretionary |
| Oct 12, 2023 | INKT | $3.5K | Purchase | 3,173 | $1.10 | Discretionary |
| Oct 4, 2023 | INKT | $16.4K | Purchase | 15,001 | $1.09 | Discretionary |
| Aug 29, 2023 | INKT | $45.1K | Purchase | 29,678 | $1.52 | Discretionary |
| Aug 28, 2023 | INKT | $18.6K | Purchase | 12,808 | $1.45 | Discretionary |
| Aug 24, 2023 | INKT | $262.2K | Purchase | 170,244 | $1.54 | Discretionary |
| May 11, 2023 | INKT | $33.4K | Purchase | 23,361 | $1.43 | Discretionary |
| May 10, 2023 | INKT | $33.3K | Purchase | 22,065 | $1.51 | Discretionary |
| May 5, 2023 | INKT | $95.0K | Purchase | 100,000 | $0.95 | Discretionary |
| May 5, 2023 | INKT | $250 | Purchase | 200 | $1.25 | Discretionary |
| May 4, 2023 | INKT | $26.2K | Purchase | 21,473 | $1.22 | Discretionary |
| May 3, 2023 | INKT | $139.0K | Purchase | 128,689 | $1.08 | Discretionary |
| May 1, 2023 | INKT | $0 | Other | 4,988,273 | $N/A | Discretionary |
| May 1, 2023 | INKT | $0 | Other | 5,006,397 | $N/A | Discretionary |
| Oct 19, 2021 | INKT | $16.8M | Purchase | 1,400,000 | $12.00 | Discretionary |
| Oct 19, 2021 | INKT | $0 | Conversion | 5,451,958 | $N/A | Discretionary |